These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8485707)
21. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer. Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625 [TBL] [Abstract][Full Text] [Related]
22. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
23. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317 [TBL] [Abstract][Full Text] [Related]
25. Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs. Hogge GS; Burkholder JK; Culp J; Albertini MR; Dubielzig RR; Yang NS; MacEwen EG Cancer Gene Ther; 1999; 6(1):26-36. PubMed ID: 10078961 [TBL] [Abstract][Full Text] [Related]
26. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. Guan J; Ma L; Wei L Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195 [TBL] [Abstract][Full Text] [Related]
27. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Grignani F; Kinsella T; Mencarelli A; Valtieri M; Riganelli D; Grignani F; Lanfrancone L; Peschle C; Nolan GP; Pelicci PG Cancer Res; 1998 Jan; 58(1):14-9. PubMed ID: 9426049 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells. Clary BM; Coveney EC; Philip R; Blazer DG; Morse M; Gilboa E; Lyerly HK Cancer Gene Ther; 1997; 4(2):97-104. PubMed ID: 9080118 [TBL] [Abstract][Full Text] [Related]
30. Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cells. Lechanteur C; Moutschen M; Princen F; Lopez M; Franzen E; Gielen J; Bours V; Merville MP Cancer Gene Ther; 2000 May; 7(5):676-82. PubMed ID: 10830715 [TBL] [Abstract][Full Text] [Related]
31. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Reeves ME; Royal RE; Lam JS; Rosenberg SA; Hwu P Cancer Res; 1996 Dec; 56(24):5672-7. PubMed ID: 8971174 [TBL] [Abstract][Full Text] [Related]
32. Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells. Grabarczyk P; Wysocki PJ; Gryska K; Mackiewicz A Acta Biochim Pol; 2002; 49(2):333-9. PubMed ID: 12362974 [TBL] [Abstract][Full Text] [Related]
33. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ. Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779 [TBL] [Abstract][Full Text] [Related]
34. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy. Stagg J; Wu JH; Bouganim N; Galipeau J Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233 [TBL] [Abstract][Full Text] [Related]
35. Abrogation of TGF-beta activity during retroviral transduction improves murine hematopoietic progenitor and repopulating cell gene transfer efficiency. Yu J; Soma T; Hanazono Y; Dunbar CE Gene Ther; 1998 Sep; 5(9):1265-71. PubMed ID: 9930329 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of adenoviral transduction with polycationic liposomes in vivo. Lee SG; Yoon SJ; Kim CD; Kim K; Lim DS; Yeom YI; Sung MW; Heo DS; Kim NK Cancer Gene Ther; 2000 Oct; 7(10):1329-35. PubMed ID: 11059690 [TBL] [Abstract][Full Text] [Related]
37. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327 [TBL] [Abstract][Full Text] [Related]
38. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Rancourt C; Bergeron C; Lane D; Garon G; Piché A Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047 [TBL] [Abstract][Full Text] [Related]
39. Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer. Miller PW; Sharma S; Stolina M; Chen K; Zhu L; Paul RW; Dubinett SM Cancer Gene Ther; 1998; 5(6):380-9. PubMed ID: 9917093 [TBL] [Abstract][Full Text] [Related]
40. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor. Koren B; Weisz A; Fischer L; Gluzman Z; Preis M; Avramovitch N; Cohen T; Cosset FL; Lewis BS; Flugelman MY Cardiovasc Revasc Med; 2006; 7(3):173-8. PubMed ID: 16945825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]